Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 27 peer-reviewed journal articles Updated
Neurology · Autoimmune Encephalitis

When Tests Are Negative: Seronegative Brainstem Encephalitis

At a Glance

Seronegative brainstem encephalitis means standard antibody tests have not found a known immune marker; it can still be autoimmune. Doctors use symptoms, MRI, spinal-fluid findings, and clinical response to guide treatment and monitoring.

Being diagnosed with seronegative autoimmune brainstem encephalitis can feel like you are being handed a puzzle with a missing piece. You have been told that your immune system is attacking a critical part of your brain, yet the standard tests used to name the “culprit” (the specific antibody) have come back negative.

It is important to understand that seronegative simply means “antibody not detected” in the blood (serum) or spinal fluid [1][2]. It does not mean your condition isn’t autoimmune, and it certainly does not mean your symptoms are not real. Many people with this diagnosis respond very well to treatment, even without a positive antibody test [3][4].

Important Note: The “antibody-negative” label should only be used after appropriate serum and spinal fluid testing has been interpreted by a specialist.

Understanding the “Seronegative” Label

In many autoimmune diseases, doctors look for a specific antibody—a protein the immune system creates to attack a target. In a substantial proportion of autoimmune encephalitis cases, these tests do not find a known antibody [1]. There are several reasons why this happens:

  • Undiscovered Antibodies: Science has not yet identified every possible antibody that can cause brain inflammation. You may have an antibody that researchers haven’t named yet [5].
  • Test Limitations: Sometimes an antibody is present but at levels too low for current tests to detect, or the test timing was impacted by previous treatments (like steroids). The antibody may also only be present in the spinal fluid rather than the blood [6][5].
  • Other Immune Mechanisms: The immune system is complex; sometimes different parts of the system, like specific immune cells, cause the inflammation without involving measurable antibodies at all.

Why Your Brainstem Matters

The brainstem is the “control center” for your body’s most basic, life-sustaining functions [7]. It sits at the base of your brain and acts as a bridge to your spinal cord. Because it is so densely packed with vital pathways, even small amounts of inflammation here can cause significant symptoms [8].

When the immune system mistakenly inflames the brainstem, it can disrupt:

  • Swallowing and Speech: The brainstem coordinates the complex muscles used for eating and talking. Inflammation can lead to dysphagia (difficulty swallowing) or dysarthria (slurred speech) [9][10].
  • Balance and Coordination: This area processes signals from your inner ears and eyes. Disruptions can cause vertigo (a spinning sensation) or ataxia (clumsiness or shaky movements) [11][10].
  • Eye Movements: The brainstem controls the nerves that move your eyes. Inflammation often causes diplopia (double vision) or nystagmus (involuntary jumping of the eyes) [8][9].
  • Automatic Functions: In some cases, the brainstem’s control over “automatic” tasks like breathing or heart rate can be affected, which is why close monitoring is essential during the active phase of the disease [12][13].

The Emotional Weight of a Rare Diagnosis

Receiving a diagnosis that is both rare and “non-specific” is a heavy emotional burden. Autoimmune encephalitis itself is uncommon, and brainstem-only presentations are even rarer [14][15].

It is normal to feel:

  • Invisible or Disbelieved: Without a “positive” lab test to point to, you may worry that others (or even some doctors) won’t take your symptoms seriously. This “diagnostic uncertainty” is a recognized psychological stressor that can lead to anxiety and isolation [16][17].
  • Isolated: Because this condition is rare, your local doctor may have limited experience with it. This often means you have to become your own advocate or travel to see a neuroimmunologist—a specialist in how the immune system affects the brain [18][19].
  • Frustrated by the “Odyssey”: Many patients go through a long “diagnostic odyssey” of repeated scans and tests before reaching this point. The lack of a clear-cut lab result does not change the fact that your experiences are valid and require expert care [20][21].

Moving Forward with Treatment

Even without an antibody name, doctors can support this probable diagnosis based on your symptoms, MRI scans, and cerebrospinal fluid (CSF) analysis [2][5]. Current guidelines emphasize that treatment should not be delayed just because an antibody test is negative [22][23].

Treatment typically begins with immunotherapy, which aims to calm the immune system. This often includes high-dose steroids, IVIG (intravenous immunoglobulin), or plasmapheresis (plasma exchange) [24][25]. While the journey may be longer when the “culprit” isn’t named, a significant portion of people with seronegative autoimmune encephalitis achieve a favorable functional recovery [3]. Focus on working with a team that validates your experience and monitors your progress through physical exams and functional improvements rather than just lab results [26][27].

Common questions in this guide

What does seronegative mean in autoimmune brainstem encephalitis?
Seronegative means that standard testing did not detect a known antibody in the blood or spinal fluid. It does not prove that the illness is not autoimmune, and it does not make the symptoms less real. A specialist should interpret the results in the context of the examination and other tests.
Can autoimmune encephalitis be diagnosed when antibody tests are negative?
Yes. A specialist may use the pattern of symptoms and examination findings, brain MRI, and spinal-fluid analysis while considering other possible causes. A negative antibody test alone does not rule out autoimmune encephalitis or necessarily mean treatment should wait.
What symptoms can brainstem inflammation cause?
Brainstem inflammation may cause difficulty swallowing, slurred speech, vertigo, poor coordination, double vision, or involuntary eye movements. In more serious cases, it can affect breathing or heart rate, so close monitoring may be needed during the active illness.
How is seronegative brainstem encephalitis treated?
Treatment generally uses immunotherapy to calm abnormal immune activity. Depending on the situation, this may include high-dose steroids, intravenous immunoglobulin, or plasma exchange. Doctors monitor symptoms, examinations, and everyday function to judge whether treatment is helping.
Should I see a neuroimmunologist for antibody-negative brainstem encephalitis?
Because brainstem-only and antibody-negative presentations are uncommon, a consultation with a neuroimmunologist or rare disease center may be useful. This specialist can review whether the diagnosis fits, consider alternative diagnoses, and help plan treatment and monitoring.
How will doctors know if treatment is working without an antibody marker?
Doctors can track changes in symptoms, neurological examinations, swallowing and breathing safety, and everyday function. Improvement in these areas can show that treatment is helping even when no antibody is available to measure.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Since my antibody tests were negative, what clinical criteria are you using to confirm my diagnosis of autoimmune encephalitis?
  2. 2.Which specific brainstem functions are most affected by the inflammation seen on my scans or in my clinical exams?
  3. 3.Given the rarity of this presentation, do you recommend a consultation with a neuroimmunology specialist or a rare disease center?
  4. 4.How will we measure whether the immunotherapy is working if there is no antibody marker to track?
  5. 5.Are there any alternative diagnoses, such as CLIPPERS or MOGAD, that you have considered and ruled out?
  6. 6.What is the plan for monitoring my swallowing and breathing safety as I begin treatment?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (27)
  1. 1

    Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes.

    Lee WJ, Lee HS, Kim DY, et al.

    Brain : a journal of neurology 2022; (145(10)):3509-3521 doi:10.1093/brain/awac166.

    PMID: 35512357
  2. 2

    Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease.

    Dalmau J, Graus F

    The Lancet. Neurology 2023; (22(6)):529-540 doi:10.1016/S1474-4422(23)00083-2.

    PMID: 37210100
  3. 3

    Long-Term Outcomes in Antibody-Negative Autoimmune Encephalitis: A Systematic Review and Meta-Analysis.

    Mohapatra P, Chandu M, Kumar P, et al.

    Neurology. Clinical practice 2026; (16(2)):e200602 doi:10.1212/CPJ.0000000000200602.

    PMID: 42302198
  4. 4

    Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort.

    Lee WJ, Lee ST, Byun JI, et al.

    Neurology 2016; (86(18)):1683-91 doi:10.1212/WNL.0000000000002635.

    PMID: 27037228
  5. 5

    A clinical approach to diagnosis of autoimmune encephalitis.

    Graus F, Titulaer MJ, Balu R, et al.

    The Lancet. Neurology 2016; (15(4)):391-404.

    PMID: 26906964
  6. 6

    Current and Future Biomarkers in the Diagnosis of Autoimmune Encephalitis: A Review of Biomarker Detection Techniques and Their Performance.

    Plačenytė P, Giedraitienė N, Vaišvilas M

    Medicina (Kaunas, Lithuania) 2026; (62(5)) doi:10.3390/medicina62050896.

    PMID: 42195149
  7. 7

    Brainstem dysfunction in critically ill patients.

    Benghanem S, Mazeraud A, Azabou E, et al.

    Critical care (London, England) 2020; (24(1)):5 doi:10.1186/s13054-019-2718-9.

    PMID: 31907011
  8. 8

    The Brainstem Tau Cytoskeletal Pathology of Alzheimer's Disease: A Brief Historical Overview and Description of its Anatomical Distribution Pattern, Evolutional Features, Pathogenetic and Clinical Relevance.

    Rüb U, Stratmann K, Heinsen H, et al.

    Current Alzheimer research 2016; (13(10)):1178-97 doi:10.2174/1567205013666160606100509.

    PMID: 27264543
  9. 9

    Rhombencephalitis associated with varicella-zoster virus masquerading as Guillain-Barré syndrome.

    Al Shaaibi K, Phoophiboon V, Burns KEA

    BMC neurology 2025; (25(1)):324 doi:10.1186/s12883-025-04245-x.

    PMID: 40764927
  10. 10

    Clinical Reasoning: A 43-Year-Old Man With Subacute Onset of Vision Disturbances, Jaw Spasms, and Balance and Sleep Difficulties.

    Orozco E, Guo Y, Chen JJ, et al.

    Neurology 2022; (99(9)):387-392 doi:10.1212/WNL.0000000000200950.

    PMID: 35794020
  11. 11

    The brainstem in multiple sclerosis: MR identification of tracts and nuclei damage.

    Nguyen TH, Vaussy A, Le Gaudu V, et al.

    Insights into imaging 2021; (12(1)):151 doi:10.1186/s13244-021-01101-7.

    PMID: 34674050
  12. 12

    Transcription factors regulating the specification of brainstem respiratory neurons.

    Xia Y, Cui K, Alonso A, et al.

    Frontiers in molecular neuroscience 2022; (15()):1072475 doi:10.3389/fnmol.2022.1072475.

    PMID: 36523603
  13. 13

    MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.

    Jarius S, Kleiter I, Ruprecht K, et al.

    Journal of neuroinflammation 2016; (13(1)):281 doi:10.1186/s12974-016-0719-z.

    PMID: 27802825
  14. 14

    Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis.

    Dubey D, Pittock SJ, Kelly CR, et al.

    Annals of neurology 2018; (83(1)):166-177 doi:10.1002/ana.25131.

    PMID: 29293273
  15. 15

    Autoimmune Encephalitis Criteria in Clinical Practice.

    Orozco E, Valencia-Sanchez C, Britton J, et al.

    Neurology. Clinical practice 2023; (13(3)):e200151 doi:10.1212/CPJ.0000000000200151.

    PMID: 37124463
  16. 16

    Diagnostic uncertainty in patients, parents, and physicians: a compensatory control theory perspective.

    McKoane A, Sherman DK

    Health psychology review 2023; (17(3)):439-455 doi:10.1080/17437199.2022.2086899.

    PMID: 35672909
  17. 17

    How Patients with an Uncertain Diagnosis Experience Intolerance of Uncertainty: A Grounded Theory Study.

    Yang Z, Zhao X, Zhu Z, et al.

    Psychology research and behavior management 2021; (14()):1269-1279 doi:10.2147/PRBM.S318263.

    PMID: 34408511
  18. 18

    Assessing healthcare experiences and barriers to care among individuals with ectodermal dysplasia.

    Swanson AK, Hammersmith KJ, Peng J, et al.

    Orphanet journal of rare diseases 2026; (21(1)).

    PMID: 41787517
  19. 19

    Multidisciplinary Care of Patients with Inherited Metabolic Diseases and Epilepsy: Current Perspectives.

    Tumienė B, Del Toro Riera M, Grikiniene J, et al.

    Journal of multidisciplinary healthcare 2022; (15()):553-566 doi:10.2147/JMDH.S251863.

    PMID: 35387391
  20. 20

    Harmful words: A qualitative survey of pain clinicians' perspectives on unhelpful messages in chronic pain.

    Jordan A, Brook-Rowland P, Noel M, Gauntlett-Gilbert J

    The journal of pain 2025; (35()):105524 doi:10.1016/j.jpain.2025.105524.

    PMID: 40783171
  21. 21

    How the clinical encounter shapes diagnostic uncertainty in pediatric chronic pain.

    Neville A, Clemente I, Meldrum ML, et al.

    The journal of pain 2025; (32()):105406 doi:10.1016/j.jpain.2025.105406.

    PMID: 40287028
  22. 22

    Autoimmune Encephalitis Misdiagnosis in Adults.

    Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, et al.

    JAMA neurology 2023; (80(1)):30-39 doi:10.1001/jamaneurol.2022.4251.

    PMID: 36441519
  23. 23

    Systematic Review and Meta-Analysis of the Clinical Features Associated With Seronegative Autoimmune Encephalitis.

    Di Cosmo L, Mulic-Al Bunni S, Goh Y, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2026; (13(2)):e200540 doi:10.1212/NXI.0000000000200540.

    PMID: 41499723
  24. 24

    Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management.

    Abboud H, Probasco JC, Irani S, et al.

    Journal of neurology, neurosurgery, and psychiatry 2021; (92(7)):757-768 doi:10.1136/jnnp-2020-325300.

    PMID: 33649022
  25. 25

    An Update on the Treatment of Pediatric Autoimmune Encephalitis.

    Stingl C, Cardinale K, Van Mater H

    Current treatment options in rheumatology 2018; (4(1)):14-28 doi:10.1007/s40674-018-0089-z.

    PMID: 29780690
  26. 26

    Patient-Reported Outcome Measures in NMDA Receptor Encephalitis.

    Heine J, Boeken OJ, Rekers S, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2025; (12(1)):e200343 doi:10.1212/NXI.0000000000200343.

    PMID: 39671210
  27. 27

    Subjective neuropsychological deficits in autoimmune encephalitis: Patient-informant discrepancies and cognitive test outcomes.

    Ko KY, Seery N, Kazzi C, et al.

    Journal of the neurological sciences 2025; (478()):123709 doi:10.1016/j.jns.2025.123709.

    PMID: 41075676

This page explains seronegative autoimmune brainstem encephalitis for educational purposes and does not replace medical advice. A neurologist or neuroimmunologist should interpret your test results and guide your treatment and monitoring.

Get notified when new evidence is published on Non-specific autoimmune brainstem encephalitis without characteristic antibodies.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.